| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 612.52M | 499.50M | 383.46M | 418.41M | 247.87M |
| Gross Profit | 322.80M | 253.76M | 183.25M | 251.84M | 166.40M |
| EBITDA | 323.07M | 247.96M | 196.92M | 222.79M | 135.63M |
| Net Income | 107.78M | 104.76M | 65.03M | 83.21M | 41.62M |
Balance Sheet | |||||
| Total Assets | 2.29B | 1.25B | 1.22B | 994.80M | 948.75M |
| Cash, Cash Equivalents and Short-Term Investments | 1.13B | 639.60M | 593.50M | 282.19M | 182.40M |
| Total Debt | 244.90M | 746.00K | 30.00M | 30.00M | 30.00M |
| Total Liabilities | 692.63M | 201.50M | 241.97M | 235.71M | 300.98M |
| Stockholders Equity | 1.36B | 883.46M | 911.40M | 553.87M | 597.73M |
Cash Flow | |||||
| Free Cash Flow | 79.72M | 169.64M | 97.21M | 167.73M | 58.59M |
| Operating Cash Flow | 215.86M | 212.19M | 174.33M | 232.93M | 135.77M |
| Investing Cash Flow | -142.84M | -56.98M | -75.51M | -56.06M | -87.80M |
| Financing Cash Flow | 395.63M | -107.18M | 206.31M | -54.79M | -45.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$1.52B | 3.46 | 42.54% | ― | 63.46% | 225.78% | |
77 Outperform | HK$15.14B | 14.89 | 23.61% | 0.44% | 49.31% | 262.43% | |
66 Neutral | HK$2.64B | 18.61 | 10.43% | 2.78% | 26.00% | 1.94% | |
64 Neutral | HK$28.64B | 13.75 | 33.81% | 1.40% | 10.57% | 112.84% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
54 Neutral | HK$4.32B | 21.71 | 18.35% | ― | 59.18% | 28.00% | |
40 Underperform | HK$798.66M | -31.17 | -1.02% | ― | ― | -25.51% |